Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets CE Mark for Molecular SARS-CoV-2 Test With Saliva Samples

NEW YORK – Roche announced on Friday that its Cobas SARS-CoV-2 Qualitative test has received CE marking for use with saliva samples.

The RT-PCR test runs on the fully automated Cobas 6800/8800 systems and is intended for use by symptomatic and asymptomatic people, the company said in a statement. Patients have the option to self-collect their saliva sample on site under the guidance of a healthcare professional, Roche added. 

The test has already been available to use with nasal, nasopharyngeal, and oropharyngeal swabs collected by a healthcare professional, Roche added.

"Expanding sensitive testing to include a noninvasive, easy-to-collect sample type such as saliva helps to improve access to screening for more people," Cindy Perettie, head of molecular labs at Roche Diagnostics, said in a statement. "This is crucial for public health and keeping our communities safe."

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.